Cargando…
Maternal Plasma and Amniotic Fluid Chemokines Screening in Fetal Down Syndrome
Objective. Chemokines exert different inflammatory responses which can potentially be related to certain fetal chromosomal abnormalities. The aim of the study was to determine the concentration of selected chemokines in plasma and amniotic fluid of women with fetal Down syndrome. Method. Out of 171...
Autores principales: | Laudanski, Piotr, Zbucka-Kretowska, Monika, Charkiewicz, Karol, Wolczynski, Slawomir, Wojcik, Daniela, Charkiewicz, Radoslaw |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248337/ https://www.ncbi.nlm.nih.gov/pubmed/25477715 http://dx.doi.org/10.1155/2014/835837 |
Ejemplares similares
-
Maternal Plasma and Amniotic Fluid Sphingolipids Profiling in Fetal Down Syndrome
por: Charkiewicz, Karol, et al.
Publicado: (2015) -
Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome
por: Charkiewicz, Karol, et al.
Publicado: (2016) -
Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome
por: Zbucka-Kretowska, Monika, et al.
Publicado: (2017) -
Chemokines Profiling of Patients with Preterm Birth
por: Laudanski, Piotr, et al.
Publicado: (2014) -
The Significance of Apolipoprotein E Measurement in the Screening of Fetal Down Syndrome
por: Buczyńska, Angelika, et al.
Publicado: (2020)